Oaktree Acquisition CORP Iii Life Sciences 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

NASDAQ
Oaktree Acquisition Corp. III Life Sciences, a blank check company, reported net income for 2025 but faces substantial doubt about its ability to continue as a going concern due to its business combination deadline.
NASDAQ
Oaktree Acquisition Corp. III Life Sciences outlines the terms and conditions of its securities, including ordinary shares, warrants, and units, in its latest 10-K filing.